Professor & Canada Research Chair in Neuroepidemiology and Multiple Sclerosis
Expertise

Multiple sclerosis, epidemiology, pharmacoepidemiology, natural history, prognosis and predictors of disease progression, mortality, drug effectiveness, adverse drug effects, pharmacogenomics, incidence and prevalence, life expectancy, comorbidities, pregnancy, impact of parental MS on childhood developmental outcomes, health administrative data, prodrome, gut microbiome, microbiota